AnteoTech (ADO) Stock Price, News & Analysis

Company Overview

AnteoTech Limited develops, commercializes, manufactures, and distributes products for clean energy technology and life science markets primarily in Australia, Asia, Europe, and North America. Its products include AnteoBind ready-to-use applications to streamline and enhance the conjugation process; and AnteoX, an additive that reinforces battery binders helping maximize performance of silicon containing anodes. The company was formerly known as Anteo Diagnostics Limited and changed its name to AnteoTech Limited in November 2019. AnteoTech Limited is headquartered in Eight Mile Plains, Australia.

Key Stats

• Today's Range: N/A
• 50-Day Range: N/A
• 52-Week Range: N/A
• Volume: 1.43 million shs
• Average Volume: N/A
• Market Capitalization: A$43.28 million
• P/E Ratio: N/A
• Dividend Yield: 5.08%
• Price Target: N/A
• Consensus Rating: N/A

ADO Stock Analysis - Frequently Asked Questions

How were AnteoTech's earnings last quarter?

AnteoTech Limited (ASX:ADO) posted its quarterly earnings results on Wednesday, February, 27th. The company reported $0.00 earnings per share for the quarter. AnteoTech had a negative trailing twelve-month return on equity of 176.60% and a net margin of 267.46%.

What other stocks do shareholders of AnteoTech own?

Based on aggregate information from My MarketBeat watchlists, some other companies that AnteoTech investors own include Lepidico (LPD), NOVONIX (NVX), Meta Platforms (META), Lyft (LYFT), NeuRizer (LCK), Evolution Mining (EVN) and Emerge Gaming (EM1).

Company Calendar

• Last Earnings: 2/27/2019
• Today: 7/06/2025

Industry, Sector and Symbol

• Stock Exchange: ASX
• Sector: Medical
• Industry: Biotechnology
• Sub-Industry: Personal Services
• Current Symbol: ASX:ADO
• CIK: N/A
• Web: www.anteodx.com
• Phone: 61 7 3219 0085
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -A$8.88 million
• Net Margins: 267.46%
• Pretax Margin: N/A
• Return on Equity: -176.60%
• Return on Assets: -75.75%

Debt

• Debt-to-Equity Ratio: 43.55
• Current Ratio: 3.04
• Quick Ratio: 6.54

Sales & Book Value

• Annual Sales: A$1.02 million
• Price / Sales: 0.00
• Cash Flow: N/A
• Price / Cash Flow: 22.00
• Book Value: A$0.00 per share
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 2,490,000,000
• Free Float: N/A
• Market Cap: A$43.28 million
• Optionable: Not Optionable
• Beta: 1.34